Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy is effective for diagnosing and monitoring female pattern hair loss.

Repeated botulinum toxin injections for forehead wrinkles may cause hairline recession in some women.

The document concludes that using autologous follicular unit implantation is a successful method to correct hairline deformities after facial rejuvenation.

Many women's hair loss is due to health issues, medication, nutrition, or stress.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Dr. Rochelle Torgerson says female-pattern hair loss is often hereditary, starts after puberty, and can be slowed with treatments like Minoxidil. It can also indicate other health issues.

Androgenetic alopecia in women needs more research and better management strategies.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Frontal fibrosing alopecia causes hair loss along the frontal hairline, mainly in postmenopausal women, and needs better treatments.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Isolated long hairs at the original hairline can help diagnose Frontal Fibrosing Alopecia.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Men with lichen planopilaris had earlier onset than women, and treatment usually improved the condition.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.